A Stability Indicating Reverse Phase-HPLC Method Development and Validation for the Estimation of Rucaparib in Bulk and Pharmaceutical Dosage Form

ISSN Print: 2156-8251
ISSN Online: 2156-8278
www.scirp.net/journal/ajac
E-mail: [email protected]

Citations

"A Stability Indicating Reverse Phase-HPLC Method Development and Validation for the Estimation of Rucaparib in Bulk and Pharmaceutical Dosage Form"
written by D. Suchitra, Satyanarayana Battu,
published by American Journal of Analytical Chemistry, Vol.12 No.4, 2021

has been cited by the following article(s):

[1]	Method Development and Validation of the Simultaneous Analysis of Methylisothiazolinone, Methylchloroisothiazolinone, Benzisothiazolinone and Bronopol …
	American Journal of Analytical …, 2024

[2]	MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib
	ACS omega, 2023

[3]	A Novel RP-HPLC Method for Estimating Fulvestrant, Benzoyl Alcohol, and Benzyl Benzoate in Injection Formulation
	American Journal of Analytical …, 2022

[1]	Method Development and Validation of the Simultaneous Analysis of Methylisothiazolinone, Methylchloroisothiazolinone, Benzisothiazolinone and Bronopol in Washing-Up Liquid American Journal of Analytical Chemistry, 2024 DOI:10.4236/ajac.2024.151003

[2]	MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib ACS Omega, 2023 DOI:10.1021/acsomega.2c07815

[3]	A Novel RP-HPLC Method for Estimating Fulvestrant, Benzoyl Alcohol, and Benzyl Benzoate in Injection Formulation American Journal of Analytical Chemistry, 2022 DOI:10.4236/ajac.2022.137016